Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Peanut Allergy
Interventions
BIOLOGICAL

VLP Peanut

solution for subcutaneous administration

BIOLOGICAL

Placebo

solution for subcutaneous administration

BIOLOGICAL

VLP Peanut

solution for Skin-prick testing

Trial Locations (10)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

33613

RECRUITING

University of South Florida, Tampa

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

55905

RECRUITING

Mayo Clinic, Rochester

63141

RECRUITING

Washington University School of Medicine, St Louis

66160

RECRUITING

University of Kansas Medical Center, Kansas City

77008

RECRUITING

Trio Clinical Trials, LLC., Houston

85724

RECRUITING

University of Arizona, Tucson

02114

RECRUITING

Massachusetts General Hospital, Boston

53792-9988

RECRUITING

University of Wisconsin School of Medicine and Public Health Asthma, Allergy, and Pulmonary Clinical Research, Madison

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY